
Contezolid (MRX-I), a safer antibiotic of the oxazolidinone class, is a promising new antibiotic with potent activity against Mycobacterium tuberculosis (MTB) both in vitro and in vivo . To identify resistance mechanisms of contezolid in MTB, we isolated several in vitro spontaneous contezolid-resistant MTB mutants, which exhibited 16-fold increases in the MIC of contezolid compared with the parent strain but were still unexpectedly susceptible to linezolid.
Pyridones, Linezolid, Antitubercular Agents, Mycobacterium tuberculosis, Microbial Sensitivity Tests, Anti-Bacterial Agents, Mixed Function Oxygenases, Flavins, Mutation, Oxazolidinones
Pyridones, Linezolid, Antitubercular Agents, Mycobacterium tuberculosis, Microbial Sensitivity Tests, Anti-Bacterial Agents, Mixed Function Oxygenases, Flavins, Mutation, Oxazolidinones
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
